Pathological Changes in Diabetes
Mel itus
--- Content provided by FirstRanker.com ---
? Pancreas? Diabetic Nephropathy
? Diabetic Cardiomyopathy
? Diabetic Retinopathy
? Diabetic Neuropathy
--- Content provided by FirstRanker.com ---
Four distinct mechanisms
1-Formation of Advanced Glycation End Products. Advanced glycation
--- Content provided by FirstRanker.com ---
end products (AGEs) are formed as intracellular
glucose derived dicarbonyl precursors+ amino groups
--- Content provided by FirstRanker.com ---
advanced glycation end product(AGEs)(glyoxal, methylglyoxal, and 3-deoxyglucosone)
? AGEs bind to a specific receptor (RAGE) that is expressed on
--- Content provided by FirstRanker.com ---
inflammatory cells (macrophages and T cells), endothelium, and
vascular smooth muscle.
--- Content provided by FirstRanker.com ---
AGE-RAGE signal ing axis? TGF-excess basement membrane material
? vascular endothelial growth factor (VEGF)- neovasculerization
? reactive oxygen species (ROS) in endothelial cells
--- Content provided by FirstRanker.com ---
? procoagulant activity? Enhanced proliferation of vascular smooth muscle cells and synthesis
of extracellular matrix
2-Activation of Protein Kinase C.
--- Content provided by FirstRanker.com ---
second messenger diacyl glycerol (DAG) is an important signaltransduction pathway.
Intracellular hyperglycemia--- de novo synthesis of DAG--excessive
--- Content provided by FirstRanker.com ---
PKC activation- vascular permeability and angiogenesis3-Oxidative Stress and Disturbances in Polyol Pathways
? Sustained hyperglycemia---- aldol reductase-- progressive depletion of
--- Content provided by FirstRanker.com ---
intracellular NADPH -- decreased rgeneration of reduced
glutathione(GSH) - increasing cellular susceptibility to oxidative
--- Content provided by FirstRanker.com ---
stress4-Hexosamine Pathways and Generation of Fructose-6- Phosphate
Hyperglycemia ---increases intracellular levels of fructose-6-
phosphate via HM- excess proteoglycans - abnormal
expression of TGF or PAI-1--- exacerbate the end-organ damage
--- Content provided by FirstRanker.com ---
Pancreas
Pancreatic Islets-
1-Insulitis:
--- Content provided by FirstRanker.com ---
? In type 1 DM-?lymphocytic infiltrate,macrophage and few polymorphs
? In type 2 DM-
?variable degree of fibrous tissue in the islets
--- Content provided by FirstRanker.com ---
2-Islet cell mass:
? Type-1- loss of pancreatic -cells and its hyalinisation
? In type 2 DM-hyperplasia and hypertrophy of islets
3-Amyloidosis:
--- Content provided by FirstRanker.com ---
? type 1 DM- absent? Type-2DM-around the capillaries of the islets causing compression
and atrophy of islet tissue
--- Content provided by FirstRanker.com ---
Diabetic Nephropathy
Nephrosclerosis
--- Content provided by FirstRanker.com ---
Pathogenesis in Diabetic nephropathy
--- Content provided by FirstRanker.com ---
Diabetic Retinopathy
--- Content provided by FirstRanker.com ---
--- Content provided by FirstRanker.com ---
Intra retinal microangiopathy (IRMA)(NPDR)
Neovascularization
--- Content provided by FirstRanker.com ---
Diabetic Cardiomyopathy
--- Content provided by FirstRanker.com ---
Diabetic Neuropathy--- Content provided by FirstRanker.com ---